Sartorius Appoints New Head of Lab Products & Services Division - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Sartorius Appoints New Head of Lab Products & Services Division



Sartorius has appointed Michael Melingo to head marketing, sales, and services of the Lab Products & Services Division effective April 1, 2014. He will succeed Dominique Baly, who will retire from the company. Melingo will report to the CEO and Executive Board Chairman, Joachim Kreuzburg, and become a member of the Group Executive Committee. Previously, Melingo worked at Metrohm, a Swiss manufacturer of analytical instruments, where he was CEO of its US subsidiary. He has also worked for Baxter, Bio-Rad, Millipore, and Waters in Europe and Asia.

Source: Sartorius

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
11%
Provide treatment for patients globally.
8%
All of the above.
42%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here